Literature DB >> 22972355

[Inflammatory choroidal neovascularisations].

S Winterhalter1, A M Joussen, U Pleyer, N Stübiger.   

Abstract

Inflammation plays a key role in the induction of choroidal neovascular membranes (CNV). This explains why each form of posterior uveitis may lead to CNV formation. Diseases like presumed ocular histoplasmosis syndrome (POHS), multifocal choroiditis (MFC) or punctate inner choroidopathy (PIC) carry a high risk of CNV creation. Inflammatory processes mostly cause classical membranes. Because of the classical membrane form, smaller membrane size and the younger age of the patients' inflammatory membranes are often better treatable than membranes in AMD patients. In the times before VEGF inhibition inflammatory membranes were treated with argon laser coagulation and later with PDT. Nowadays better visual acuity results are achievable through VEGF inhibitor injections with or without PDT. This is proven by a few publications with greater numbers of patients because of the rarity of the diseases and several case reports in the literature. In addition to CNV treatment the control of intraocular inflammation should never be forgotten because it forms the leading CNV trigger. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22972355     DOI: 10.1055/s-0032-1315249

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  7 in total

1.  Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to punctate inner choroidopathy.

Authors:  T Barth; F Zeman; H Helbig; M-A Gamulescu
Journal:  Int Ophthalmol       Date:  2017-04-19       Impact factor: 2.031

2.  [White dot syndromes : Principles, diagnostics, and treatment].

Authors:  Dominika Pohlmann; Sibylle Winterhalter; Uwe Pleyer
Journal:  Ophthalmologe       Date:  2019-12       Impact factor: 1.059

3.  Ranibizumab in choroidal neovascularisation associated with ocular sarcoidosis.

Authors:  Vasileios Efstathios Konidaris; Theodoros Empeslidis
Journal:  BMJ Case Rep       Date:  2013-11-14

4.  Genome-wide expression differences in anti-Vegf and dexamethasone treatment of inflammatory angiogenesis in the rat cornea.

Authors:  Pierfrancesco Mirabelli; Anthony Mukwaya; Anton Lennikov; Maria Xeroudaki; Beatrice Peebo; Mira Schaupper; Neil Lagali
Journal:  Sci Rep       Date:  2017-08-15       Impact factor: 4.379

5.  Course of disease in multifocal choroiditis lacking sufficient immunosuppression: a case report.

Authors:  Katharina Schroeder; Tobias Meyer-Ter-Vehn; Heidi Fassnacht-Riederle; Rainer Guthoff
Journal:  J Med Case Rep       Date:  2016-10-24

6.  Inflammatory choroidal neovascularization in Indian eyes: Etiology, clinical features, and outcomes to anti-vascular endothelial growth factor.

Authors:  Rupak Roy; Kumar Saurabh; Aditya Bansal; Amitabh Kumar; Anindya Kishore Majumdar; Swakshyar Saumya Paul
Journal:  Indian J Ophthalmol       Date:  2017-04       Impact factor: 1.848

Review 7.  An update on inflammatory choroidal neovascularization: epidemiology, multimodal imaging, and management.

Authors:  Aniruddha Agarwal; Alessandro Invernizzi; Rohan Bir Singh; William Foulsham; Kanika Aggarwal; Sabia Handa; Rupesh Agrawal; Carlos Pavesio; Vishali Gupta
Journal:  J Ophthalmic Inflamm Infect       Date:  2018-09-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.